Icosavax, Inc.
ICVXDelisted Feb 20, 2024- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001786255
Icosavax, Inc. was delisted on Feb 20, 2024; its insiders filed their last Form 4 on Feb 20, 2024; 93 institutions reported holding it in 13F filings for Q4 2023, worth $663.0M in total; no superinvestor held it.
Holders of 5% or more of ICVX
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Icosavax, Inc., largest stake first. The change is against the holder's previous filing.
No holder currently reports owning 5% or more of Icosavax, Inc. on Schedule 13D or 13G.
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
25 Schedule 13D and 13G filings on Icosavax, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Feb 21, 2024 | Qiming U.S. Healthcare GP II, LLC | 13D/AOld format | – | – | – | SEC |
| Feb 21, 2024 | Ra Capital Management, L.P. | 13D/AOld format | – | – | – | SEC |
| Feb 14, 2024 | T. Rowe Price Investment Management, Inc. | 13GOld format | – | – | – | SEC |
| Feb 14, 2024 | Citadel Advisors LLC | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2024 | Pentwater Capital Management LP | 13GOld format | – | New | – | SEC |
| Feb 12, 2024 | Platinum Investment Management Ltd | 13GOld format | – | – | – | SEC |
| Feb 7, 20245:09 PM ET | BlackRock Inc. | 13G/AOld format | – | – | – | SEC |
| Feb 2, 20243:57 PM ET | BlackRock Inc. | 13GOld format | – | New | – | SEC |
| Jan 10, 2024 | FMR LLC | 13G/AOld format | – | – | – | SEC |
| Nov 24, 2023 | Adams Street Partners LLC | 13D/AOld format | – | – | – | SEC |
| Jul 25, 2023 | TCG Crossover GP I, LLC | 13GOld format | – | New | – | SEC |
| Jun 13, 2023 | Adams Street Partners LLC | 13D/AOld format | – | – | – | SEC |
| Jun 5, 2023 | Citadel Advisors LLC | 13GOld format | – | New | – | SEC |
| May 30, 2023 | Ra Capital Management, L.P. | 13D/AOld format | – | – | – | SEC |
| Feb 14, 2023 | NanoDimension III, L.P. | 13G/AOld format | – | – | – | SEC |
| Feb 9, 2023 | Platinum Investment Management Ltd | 13GOld format | – | New | – | SEC |
| Jan 10, 2023 | T. Rowe Price Investment Management, Inc. | 13GOld format | – | New | – | SEC |
| Jan 10, 2023 | FMR LLC | 13GOld format | – | New | – | SEC |
| Dec 21, 2022 | Adams Street Partners LLC | 13D/AOld format | – | – | – | SEC |
| Feb 28, 2022 | Qiming U.S. Healthcare GP II, LLC | 13DOld format | – | New | – | SEC |
| Feb 10, 2022 | NanoDimension III, L.P. | 13G/AOld format | – | – | – | SEC |
| Feb 8, 2022 | Sanofi | 13GOld format | – | New | – | SEC |
| Aug 13, 2021 | NanoDimension III, L.P. | 13GOld format | – | New | – | SEC |
| Aug 12, 2021 | Adams Street Partners LLC | 13DOld format | – | New | – | SEC |
| Aug 12, 2021 | Ra Capital Management, L.P. | 13DOld format | – | New | – | SEC |
Form 144: proposed insider sales
13 notices from officers, directors and other affiliates planning to sell Icosavax, Inc. shares, newest first.
| Filed (ET) | Seller | Shares to sell | Market value | Planned sale | Broker | Filing |
|---|---|---|---|---|---|---|
| Jan 4, 20244:52 PM ET | Niranjan Kanesa-ThasanOfficer | 106.4K | $1.67M | Jan 4, 2024 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Dec 21, 20234:42 PM ET | Adam SimpsonOfficer · Director | 40.0K | $617.1K | Dec 21, 2023 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Dec 21, 20234:28 PM ET | Adam K SimpsonOfficer | 95.0K | $1.46M | Dec 21, 202310b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Dec 20, 20238:54 PM ET | Niranjan Kanesa-thasanOfficer | 11.9K | $183.7K | Dec 20, 202310b5-1 | Morgan Stanley Smith Barney LLC | SEC |
| Dec 20, 20238:50 PM ET | Thomas Joseph RussoOfficer | 10.8K | $166.2K | Dec 20, 202310b5-1 | Morgan Stanley Smith Barney LLC | SEC |
| Dec 20, 20238:50 PM ET | Adam K. SimpsonOfficer · Director | 62.2K | $961.5K | Dec 20, 202310b5-1 | Morgan Stanley Smith Barney LLC | SEC |
| Dec 20, 20238:44 PM ET | Cassia CearleyOfficer | 7.93K | $122.6K | Dec 20, 202310b5-1 | Morgan Stanley Smith Barney LLC | SEC |
| Dec 20, 20234:41 PM ET | Thomas RussoOfficer | 4.43K | $68.5K | Dec 20, 2023 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Dec 13, 20234:26 PM ET | Cassia CearleyOfficer | 35.0K | $548.8K | Dec 13, 202310b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Jul 31, 20239:45 PM ET | Adam K. SimpsonOfficer | 11.8K | $108.1K | Jul 31, 202310b5-1 | Morgan Stanley Smith Barney LLC | SEC |
| Jul 31, 20239:44 PM ET | Douglas Andrew HoltzmanOfficer | 10.4K | $95.1K | Jul 31, 202310b5-1 | Morgan Stanley Smith Barney LLC | SEC |
| Jul 3, 20231:23 PM ET | Douglas Andrew HoltzmanOfficer | 16.4K | $162.4K | Jul 3, 202310b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| May 23, 20235:00 PM ET | Cassia CearleyOfficer | 10.0K | $78.7K | May 23, 202310b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |